India dexamethasone market is expected to grow at an impressive rate during the forecast period. India dexamethasone is driven by the emergence of dexamethasone as a lifesaving drug for seriously ill COVID-19 patients owing to sudden outbreak and spread of pandemic COVID-19 and the world being adversely impacted by the pandemic, with no potential drug or treatment available to combat the spread and effect of the virus. At present the disease is just being controlled by taking precautions, following social distancing and taking symptomatic treatments. The surge in number of cases and increase in deaths due to the pandemic are further expected to fuel the market growth through FY2026. Studies conducted in the United Kingdom, illustrate that the drug is helpful in reducing risk of deaths by three times in patient on ventilators and about five times in patients on oxygen. Furthermore, WHO has also given green signal to the results of the studies and has asked to conduct further trials. This in turn has created rays of hope for improving the survival rate. Also, India has many manufacturing companies in the country which are producing dexamethasone in large quantities. This drug is also expected to emerge out just like hydroxychloroquine did and it is expected that like India exported the former drug, it can also export and supply dexamethasone. This in turn is expected to provide a boost to the Indian pharmaceutical industry and also create lucrative opportunities for the market growth until FY2026.

The India dexamethasone market is segmented based on type, route of administration, application, end users, company and region. Based on route of administration, the market can be split into oral and intravenous. Here, the intravenous route is expected to grow significantly since it delivers drug directly into the veins. Based on application, the market can be fragmented into asthma, rheumatoid arthritis, skin disorders, COVID-19, ulcerative colitis, lupus, allergic disorders, psoriasis and others. Among these, the COVID-19 segment is expected to register the highest growth on account of identification of this drug for improving the survival rate in serious coronavirus patients. 

Major players operating in the India dexamethasone market include Cadila Healthcare Ltd., Wockhardt Ltd., Dwarkesh Pharmaceuticals Private Limited, Schwitz Biotech, Lexine Technochem Private Limited, Mapro Lifescience, Therawin Formulations, Shervotec Pharmaceuticals, Acichem Laboratories, Quality Nexgen Pharmaceuticals Pvt Ltd and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India dexamethasone market from FY2016 to FY2019.
  • To estimate and forecast the market size of India dexamethasone market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India dexamethasone market based on type, route of administration, application, end users, company and regional distribution.
  • To identify dominant region or segment in the India dexamethasone market.
  • To identify drivers and challenges for India dexamethasone market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India dexamethasone market.
  • To identify and analyze the profile of leading players operating in India dexamethasone market.
  • To identify key sustainable strategies adopted by market players in India dexamethasone market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of India dexamethasone market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Dexamethasone manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to dexamethasone
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India dexamethasone market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Dexamethasone Market, By Type:
    • Injectables
    • Capsules
    • Tablets
    • Solutions
  • India Dexamethasone Market, By Route of Administration:
    • Oral
    • Intravenous
  • India Dexamethasone Market, By Application:
    • Asthma
    • Rheumatoid Arthritis
    • Skin Disorders
    • Covid-19
    • Ulcerative Colitis
    • Lupus
    •  Allergic Disorders
    • Psoriasis
    • Others
  • India Dexamethasone Market, By End Users:
    • Hospitals
    • Clinic
    • Pharmacy
    • Others
  • India Dexamethasone Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India dexamethasone market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India dexamethasone market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on India Dexamethasone Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Brand Awareness (Aided/Unaided)

5.2.  Product Awareness

5.3.  Customer Satisfaction Analysis

5.4.  Unmet Needs/Challenges

6.    India Dexamethasone Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Injectables, Capsules, Tablets, Solutions)

6.2.2.     By Route of Administration (Oral v/s Intravenous)

6.2.3.     By Application (Asthma, Rheumatoid Arthritis, Skin Disorders, Covid-19, Ulcerative Colitis, Lupus, Allergic Disorders, Psoriasis, Others)

6.2.4.     By Patient Type (Adult, Pediatric, Geriatric)

6.2.5.     By End Users (Hospitals, Clinics, Pharmacy, Others)

6.2.6.     By Company (2019)

6.2.7.     By Region

6.3.  Product Market Map

7.    North India Dexamethasone Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type

7.2.2.     By Route of Administration

7.2.3.     By Application

7.2.4.     By Patient Type

7.2.5.     By End Users

8.    South India Dexamethasone Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type

8.2.2.     By Route of Administration

8.2.3.     By Application

8.2.4.     By Patient Type

8.2.5.     By End Users

9.    East India Dexamethasone Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type

9.2.2.     By Route of Administration

9.2.3.     By Application

9.2.4.     By Patient Type

9.2.5.     By End Users

10.  West India Dexamethasone Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type

10.2.2.  By Route of Administration

10.2.3.  By Application

10.2.4.  By Patient Type

10.2.5.  By End Users

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

13.  Policy & Regulatory Landscape

14.  India Economic Profile

15.  Pricing Analysis

15.1.              API

15.2.              Intermediates

15.3.              Finished Dosages

16.  Competitive Landscape

16.1.              Cadila Healthcare Ltd.

16.2.              Wockhardt Ltd.

16.3.              Dwarkesh Pharmaceuticals Private Limited

16.4.              Schwitz Biotech

16.5.              Lexine Technochem Private Limited

16.6.              Mapro Lifescience

16.7.              Therawin Formulations

16.8.              Shervotec Pharmaceuticals

16.9.              Acichem Laboratories

16.10.            Quality Nexgen Pharmaceuticals Pvt Ltd

17.  Strategic Recommendations

18.  About Us & Disclaimer


In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]